The Critical Role of Oxidative Stress in Sarcopenic Obesity
Open accessThe DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index; 62 of the 321 sources its claims cite were checked for support.
Abstract
Sarcopenic obesity (SO) is a combination of obesity and sarcopenia that primarily develops in older people. Patients with SO have high fat mass, low muscle mass, low muscle strength, and low physical function. SO relates to metabolic syndrome and an increased risk of morbimortality. The prevalence of SO varies because of lacking consensus criteria regarding its definition and the methodological difficulty in diagnosing sarcopenia and obesity. SO includes systemic alterations such as insulin resistance, increased proinflammatory cytokines, age‐associated hormonal changes, and decreased physical activity at pathophysiological levels. Interestingly, these alterations are influenced by oxidative stress, which is a critical factor in altering muscle function and the generation of metabolic dysfunctions. Thus, oxidative stress in SO alters muscle mass, the signaling pathways that control it, satellite cell functions, and mitochondrial and endoplasmic reticulum activities. Considering this background, our objectives in this review are to describe SO as a highly prevalent condition and look at the role of oxidative stress in SO pathophysiology.
Overview
CoChat Summary
TL;DR
This review argues that oxidative stress is a central mechanism in sarcopenic obesity (SO) pathophysiology, affecting skeletal muscle, liver, and adipose tissue through mitochondrial dysfunction, endoplasmic reticulum stress, and altered muscle mass control pathways. It also emphasizes that SO is highly prevalent but remains difficult to define and diagnose because of inconsistent criteria.
Key findings
- SO prevalence varies between 2% and 85%, depending on differences in SO definitions, studied populations, and diagnostic criteria/methods for obesity and sarcopenia; there are no internationally standardized criteria for diagnosing SO.
- Oxidative stress in SO is linked to mitochondrial dysfunction, ER stress, and imbalance between anabolic and catabolic muscle mass pathways; ROS activate the ubiquitin-proteasome system (including MuRF1 and atrogin-1), NF-κB, and impair PI3K/Akt/mTOR signaling, while also dysregulating satellite cell function.
- In patients, circulating oxidative stress markers such as GSH, GSSG, MDA, and 4-HNE increase in elderly patients with SO compared with nonsarcopenic nonobese, sarcopenic nonobese, and nonsarcopenic obese patients; systemic oxidative stress is also associated with muscle mass decline in elderly patients with obesity and T2DM.
- Animal-model evidence includes resveratrol preventing SO features via the PKA/LKB1/AMPK pathway, tocotrienols and green tea polyphenols increasing muscle mass, cross-sectional area, and mitochondrial enzyme activity, and Lactobacillus paracasei PS23 attenuating age-related muscle loss with higher mitochondrial function and antioxidant enzymes and lower inflammatory cytokines and oxidative stress.
Methods
- Narrative review describing SO as a highly prevalent condition and examining the role of oxidative stress in its pathophysiology.
- Synthesizes literature on SO definitions, diagnosis, general characteristics, pathophysiology, oxidative stress mechanisms, and redox-dependent mechanisms from animal models and patients.
- No systematic review, meta-analysis, primary data collection, sample size, or formal quantitative analysis is reported.
Limitations
- The paper states that there is no consensus on SO evaluation methods and definitions, so results across investigations are highly variable and difficult to compare; diagnostic methods such as CT, DXA, MRI, and BIA are complex, costly, and less feasible for large-scale research or clinical practice.
- The paper states that there is limited evidence clarifying the mechanisms involved in the redox-dependent effect of SO in human and animal models, and that most animal research tests antiobesity, antiaging, or antioxidant agents rather than directly elucidating how oxidative stress favors SO.
- Evident from the text: as a narrative review, it does not report a systematic search strategy, study quality appraisal, or quantitative synthesis, so its conclusions rely on the cited literature rather than new primary data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
26 Valid · 2 Not valid · 76 Not checked · 15 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Elevated ROS levels activate the UPS, increasing expression of the muscle-specific ubiquitin ligase MuRF1 (Muscle RING-finger protein-1) and atrogin-1.”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 4. Oxidative Stress in Sarcopenic Obesity > 4.3. Imbalance in Muscle Mass Control
What the sources say
- Partly supportedcites [87] Szentesi P. Csernoch L. Dux L. Keller-Pintér A. Changes in redox signaling in the skeletal muscle with aging Oxidative Medicine and Cellular Longevity 2019 2019 12 10.1155/2019/4617801 2-s2.0-85062088513 4617801 30800208 PMC6360032 sourceExperimental — accuracy not yet measured
Section 5, “Age-Related Muscle Loss and Oxidative Stress” (page not provided), says increased ROS activates the ubiquitin-proteasome pathway and that aging is associated with increased MuRF1 and atrogin-1 expression. It does not establish that ROS causes the increase in those ligases; it says further studies are needed to explore oxidative stress’s role in those age-related changes. (LLM, conf=0.87)
- Partly supportedcites [105] Bonaldo P. Sandri M. Cellular and molecular mechanisms of muscle atrophy Disease Models & Mechanisms 2013 6 1 25 39 10.1242/dmm.010389 2-s2.0-84872094183 23268536 PMC3529336 sourceExperimental — accuracy not yet measured
In the IGF1-Akt-FoxO signaling section (page not specified), the paper says that nNOS-induced oxidative stress during muscle disuse enhances FoxO3-mediated transcription of atrogin-1 and MuRF1. The ubiquitin-proteasome system section identifies both as muscle-specific ubiquitin ligases. The paper does not establish the broader claim that elevated ROS activates the ubiquitin-proteasome system as a whole. (LLM, conf=0.84)
- Partly supportedcites [108] Gomes M. J. Martinez P. F. Pagan L. U. Skeletal muscle aging: influence of oxidative stress and physical exercise Oncotarget 2017 8 12 20428 20440 10.18632/oncotarget.14670 2-s2.0-85015268417 28099900 PMC5386774 sourceExperimental — accuracy not yet measured
The “Reactive Oxygen Species and Skeletal Muscle Ageing” section (page not provided) states that increased ROS activates the ubiquitin-proteasome system. It does not say that ROS increases MuRF1 or atrogin-1 expression; those ligases appear only in a reference title about IGF-I suppressing their expression. (LLM, conf=0.87)
- Disputedcites [111] Altun M. Besche H. C. Overkleeft H. S. Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway The Journal of Biological Chemistry 2010 285 51 39597 39608 10.1074/jbc.M110.129718 2-s2.0-78650046347 20940294 PMC3000941 sourceExperimental — accuracy not yet measured
In “The UPS in Muscles of Aged Rats” (p. 8), the paper reports that MuRF1 and atrogin-1 expression was not higher in aged sarcopenic rats; atrogin-1 protein decreased, although MuRF1 protein increased. Its discussion (p. 11) suggests that enhanced UPS capacity may respond to damaged proteins, but does not establish that ROS activates the UPS or increases expression of both ligases. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [112] Baumann C. W. Kwak D. Liu H. M. Thompson L. V. Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality? Journal of applied physiology (Bethesda, Md.: 1985) 2016 121 5 1047 1052 10.1152/japplphysiol.00321.2016 2-s2.0-84994530411 27197856 PMC5142250 sourceExperimental — accuracy not yet measured
The ‘ROS/RNS and Muscle Quantity’ section (p. 5) says ROS production can upregulate components of the ubiquitin-proteasome system and promote protein breakdown. It does not identify MuRF1 or atrogin-1 as components whose expression increases, and it describes the mechanism in old muscle as uncertain rather than established. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Aging comes with is a decrease in anabolic hormones such as testosterone and GH.”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 3. Pathophysiology of Sarcopenic Obesity > 3.3. Hormonal Changes
What the sources say
- Supportedcites [31] Sakuma K. Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age International Journal of Endocrinology 2013 2013 12 10.1155/2013/204164 2-s2.0-84877275009 204164 23690769 PMC3639625 source
Section 3.1, “GH and Testosterone,” states that testosterone levels decrease with age and that circulating growth hormone (GH) levels decline progressively after age 30. It also describes these as age-related decreases in anabolic hormones. (LLM, conf=0.94)
- Supportedcites [41] Wang J. Leung K.-S. Chow S. K.-H. Cheung W.-H. Inflammation and age-associated skeletal muscle deterioration (sarcopaenia) Journal of orthopaedic translation 2017 10 94 101 10.1016/j.jot.2017.05.006 2-s2.0-85029079770 29662761 PMC5822997 source
The Pathogenesis of Sarcopaenia section states that serum concentrations of testosterone and growth hormone decline in ageing individuals and identifies them as anabolic hormones. (LLM, conf=0.95)
- Not checked yetcites [51] Dam P. Smid H. de Vries W. Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men The Journal of Clinical Endocrinology and Metabolism 2000 85 12 4706 4711 10.1210/jcem.85.12.7087 11134132 source
- Not checked yetcites [52] Allan C. A. Strauss B. J. G. McLachlan R. I. Body composition, metabolic syndrome and testosterone in ageing men International Journal of Impotence Research 2007 19 5 448 457 10.1038/sj.ijir.3901552 2-s2.0-34548458613 17554396 source
- Not checked yetcites [53] Waters D. L. Qualls C. R. Dorin R. I. Veldhuis J. D. Baumgartner R. N. Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes The Journals of Gerontology: Series A 2008 63 5 536 541 10.1093/gerona/63.5.536 2-s2.0-47049125873 18511760 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As mentioned above, myosteatosis has been associated with aging, limiting functional activities due to decreased muscle mass and strength [71].”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 3. Pathophysiology of Sarcopenic Obesity > 3.4. Decrease of Physical Activity
What the sources say
- Partly supportedcites [71] Zoico E. Corzato F. Bambace C. Myosteatosis and myofibrosis: relationship with aging, inflammation and insulin resistance Archives of Gerontology and Geriatrics 2013 57 3 411 416 10.1016/j.archger.2013.06.001 2-s2.0-84881666792 23809667 PMC5278642 sourceExperimental — accuracy not yet measured
The INTRODUCTION (p. 1) supports the two core elements: MS 'increases with age and adiposity' and is 'strongly related to... poorer strength and scores on performance tests (Visser 2005), as well as incident mobility disability'. However, the causal chain the claim attributes — functional limitation 'due to decreased muscle mass and strength' — is not what this paper says: the mass/function-loss route is credited to the sarcopenia literature (Janssen 2010, Glass 2010), and the DISCUSSION (p. 1) instead frames MS as a qualitative change operating where there is a 'mismatch between the age-related decrease in muscle mass and in muscle power'. The paper's own data (RESULTS/METHODS, p. 1-2: 16 healthy elderly men, none with ADL deficit, no strength or performance measures) report associations with adiposity, leptin, insulin resistance and inflammation, not with functional activities. (LLM, conf=0.72)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Protein synthesis is reduced under Os conditions [107, 108]”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 4. Oxidative Stress in Sarcopenic Obesity > 4.3. Imbalance in Muscle Mass Control
What the sources say
- Could not verifycites [107] Ali S. Garcia J. M. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review Gerontology 2014 60 4 294 305 10.1159/000356760 2-s2.0-84903538743 24731978 PMC4112511 sourceExperimental — accuracy not yet measured
The sections on mechanisms regulating skeletal muscle mass and sarcopenia pathophysiology discuss protein synthesis and report that it decreases with aging. Neither those passages nor searches for oxidative stress and reactive oxygen species link oxidative stress to reduced protein synthesis. No page numbers were provided in our copy. (LLM, conf=0.72)
- Partly supportedcites [108] Gomes M. J. Martinez P. F. Pagan L. U. Skeletal muscle aging: influence of oxidative stress and physical exercise Oncotarget 2017 8 12 20428 20440 10.18632/oncotarget.14670 2-s2.0-85015268417 28099900 PMC5386774 sourceExperimental — accuracy not yet measured
The ‘Etiology and intracellular pathways involved in aging-associated muscle changes’ section says muscle protein synthesis is blunted in aging, attributing this to changes in anabolic signaling. The ‘Reactive oxygen species and skeletal muscle ageing’ section discusses oxidative stress and ROS-related protein breakdown, but does not say oxidative stress reduces protein synthesis. The claimed condition is therefore not supported by this source. (LLM, conf=0.80)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ROS also activates muscle proteases such as caspases and calpains, leading to protein breakdown [87, 105, 108, 111, 112].”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 4. Oxidative Stress in Sarcopenic Obesity > 4.3. Imbalance in Muscle Mass Control
What the sources say
- Partly supportedcites [87] Szentesi P. Csernoch L. Dux L. Keller-Pintér A. Changes in redox signaling in the skeletal muscle with aging Oxidative Medicine and Cellular Longevity 2019 2019 12 10.1155/2019/4617801 2-s2.0-85062088513 4617801 30800208 PMC6360032 sourceExperimental — accuracy not yet measured
Section 5 (page unavailable) says ROS accumulation can increase proteolysis and activate the ubiquitin-proteasome pathway. It also reports increased calpain activity with aging, but says the role of oxidative stress in that change needs further study; it does not establish that ROS activates calpains or caspases. (LLM, conf=0.88)
- Partly supportedcites [105] Bonaldo P. Sandri M. Cellular and molecular mechanisms of muscle atrophy Disease Models & Mechanisms 2013 6 1 25 39 10.1242/dmm.010389 2-s2.0-84872094183 23268536 PMC3529336 sourceExperimental — accuracy not yet measured
The IGF1-Akt-FoxO signaling section links oxidative stress to FoxO-mediated muscle loss, and the autophagy-lysosome section describes oxidative-stress-induced muscle atrophy through autophagy. Neither passage says that ROS activates caspases or calpains; searches for those proteases found no supporting passage in our copy. (LLM, conf=0.86)
- Supportedcites [108] Gomes M. J. Martinez P. F. Pagan L. U. Skeletal muscle aging: influence of oxidative stress and physical exercise Oncotarget 2017 8 12 20428 20440 10.18632/oncotarget.14670 2-s2.0-85015268417 28099900 PMC5386774 source
The section “Reactive Oxygen Species and Skeletal Muscle Ageing” states that increased ROS production activates muscle proteases, including caspases and calpains, leading to protein breakdown. This directly supports the attributed claim. (LLM, conf=0.95)
- Could not verifycites [111] Altun M. Besche H. C. Overkleeft H. S. Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway The Journal of Biological Chemistry 2010 285 51 39597 39608 10.1074/jbc.M110.129718 2-s2.0-78650046347 20940294 PMC3000941 sourceExperimental — accuracy not yet measured
The discussion of damaged proteins (pp. 10–11) links reactive oxygen species to oxidative damage and discusses degradation through the ubiquitin–proteasome system. It does not say that ROS activate caspases or calpains to break down muscle proteins. Searches for ROS-driven activation of those proteases found no supporting passage; the paper’s reference to a “caspase-like” site concerns the proteasome, not caspases. (LLM, conf=0.75)
- Partly supportedcites [112] Baumann C. W. Kwak D. Liu H. M. Thompson L. V. Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality? Journal of applied physiology (Bethesda, Md.: 1985) 2016 121 5 1047 1052 10.1152/japplphysiol.00321.2016 2-s2.0-84994530411 27197856 PMC5142250 sourceExperimental — accuracy not yet measured
The “ROS/RNS and Muscle Quantity” section (p. 5) says ROS production can promote protein breakdown through activation of muscle proteases, including caspases and calpains. The citing sentence presents this as an established effect, whereas the review describes it as a possible mechanism and says its role in old muscle remains unclear. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
31 more claims · 4 with their cited sources checked
Create a free account to see all 119 claims and to verify the 259 references still open.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 78
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oxidative stress can also lead to ER stress, which is characterized by unfolded protein response (UPR) causing dysfunction of proteasomal degradation and autophagy, which reduces protein levels and causes an imbalance in calcium homeostasis that altogether favor a decrease in muscle mass (30, 31).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ROS alter mitochondrial function and mass, increase mitochondrial DNA damage, reduce ATP synthesis, and elicit apoptotic pathway activity, which altogether, lead to a reduction in muscle mass.”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“The pathophysiology of this condition involves a complex interplay between muscle, adipose tissue, hormonal changes, inflammation, oxidative stress and lifestyle factors, among others.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [50]
In the citing paper
“Oxidative stress adversely impacts muscle health through muscle protein breakdown60, muscle inflammation61, impaired muscle regeneration62, mitochondrial dysfunction63 and insulin resistance50.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [50]
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 2×
“It is classified as primary (associated with aging) or secondary (associated with limitedmobility, malnutrition, or chronic diseases, such as obesity) [26, 27].”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Oxidative Stress and Antioxidant Defense
Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S., & Kalayci, O. (2012) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3182439613 · Cited by 4,935 · cited 1×
“Exogenous antioxidants include ascorbic acid (vitamin C), α-tocopherol (vitamin E), and phenolic antioxidants (such as resveratrol, phenolic acids, flavonoids, selenium, zinc, and acetylcysteine) [75, 80, 81].”
BackgroundOxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979 · cited 6×
“In this regard, aging causes the loss of type II muscle fibers more than type I, probably because type II fibers have a low mitochondrial quantity, making them more susceptible to degradation and loss of muscle mass [75, 87, 88].”
BackgroundInfluentialSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
Phaniendra, A., Jestadi, D. B., & Periyasamy, L. (2015) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0446-0 · Cited by 2,886 · cited 1×
“In contrast, exogenous sources include air and water pollution, tobacco, alcohol, heavy metals, drugs, industrial solvents, cooking pollutants, and radiation [75, 78, 79].”
BackgroundThe role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,806 · cited 1×
“Exogenous antioxidants include ascorbic acid (vitamin C), α-tocopherol (vitamin E), and phenolic antioxidants (such as resveratrol, phenolic acids, flavonoids, selenium, zinc, and acetylcysteine) [75, 80, 81].”
BackgroundEndoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · cited 2×
“The ER stress and Os in these conditions are related to the “nutrient-sensing” functions of ER, which affect metabolic response at the endocrine and systemic levels [91].”
BackgroundBodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Cited by
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“…mental stress), age-related changes in body composition 47 , hormonal imbalances 48 , declining neuromuscular function 49 , increased inflammation and oxidative stress 50 , reduced activity of muscle satellite cells 51 , altered energy metabolism, and impaired metabolic–vascular coupling 52 (Fig.”
Oxidative stress: Roles in skeletal muscle atrophy
Zhang, H., Qi, G., Wang, K., Yang, J., Shen, Y., Yang, X., Chen, X., Yao, X., Gu, X., Qi, L., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115664 · Cited by 301
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
Wei, S., Nguyen, T. T., Zhang, Y., Ryu, D., & Gariani, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185221 · Cited by 291
“Oxidative stress can also lead to ER stress, which is characterized by unfolded protein response (UPR) causing dysfunction of proteasomal degradation and autophagy, which reduces protein levels and causes an imbalance in calcium homeostasis that altogether favor a decrease in muscle mass (30, 31).”
BackgroundVascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions
de Lima, E. P., Tanaka, M., Lamas, C. B., Quesada, K., Detregiachi, C. R. P., Araújo, A. C., Guiguer, E. L., Catharin, V. M. C. S., de Castro, M. V. M., Junior, E. B., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092096 · Cited by 73
Sarcopenia and nervous system disorders
Yang, J., Jiang, F., Yang, M. J., & Chen, Z. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11268-8 · Cited by 85
“Oxidative stress has been linked to sarcopenia [77] and cognitive impairment [78], according to research.”
Sarcopenic Obesity: Involvement of Oxidative Stress and Beneficial Role of Antioxidant Flavonoids
Jung, U. J. (2023) · Antioxidants · doi:10.3390/antiox12051063 · Cited by 45
“In elderly individuals, oxidative stress elicits sarcopenia and obesity through mitochondrial dysfunction, endoplasmic reticulum (ER) stress, and imbalances in muscle mass control [17].”
BackgroundInfluentialCapozzi, A., Saucier, C., Bisbal, C., & Lambert, K. (2022) · Molecules · doi:10.3390/molecules27196594 · Cited by 43
“NFκB activity can be increased by ROSP but also by several other stimuli such as free fatty acids (FFA), advanced glycation products, and inflammatory cytokines induced by oxidative stress [19].”
BackgroundExploring the Intricate Nexus of Sarcopenia and Cognitive Impairment
Xing, Y., Li, X., & Ma, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.1013 · Cited by 30
“Oxidative stress influences altered muscle function [25].”
Wu, H., Gu, Y., Wang, X., Meng, G., Rayamajhi, S., Thapa, A., Zhang, Q., Liu, L., Zhang, S., Zhang, T., et al. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac241 · Cited by 29
Aging, Physical Exercise, Telomeres, and Sarcopenia: A Narrative Review
Hernández-Álvarez, D., Rosado-Pérez, J., Gavia-García, G., Arista-Ugalde, T. L., Aguíñiga-Sánchez, I., Santiago‐Osorio, E., & Mendoza-Núñez, V. M. (2023) · Biomedicines · doi:10.3390/biomedicines11020598 · Cited by 29
Fang, W.-W., Wang, K., Zhou, F., Ou-yang, J., Zhang, Z., Liu, C., Zeng, H., Huang, J., & Liu, Z.-H. (2023) · Food & Function · doi:10.1039/d2fo03577d · Cited by 24
Fico, B. G., Maharaj, A., Pena, G. S., & Huang, C. (2023) · Biology · doi:10.3390/biology12060865 · Cited by 19
“Mechanistically, oxidative stess seem to play a critical role in exacerbating the negative effects of sarcopenic obesity [143], which is associated with CVD risk [80,144,145]).”
BackgroundQuint, E. E., Liu, Y., Shafaat, O., Ghildayal, N., Crosby, H., Kamireddy, A., Pol, R. A., Orandi, B. J., Segev, D. L., Weiss, C. R., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.11.002 · Cited by 15
Guan, Z., Stephan, B. C. M., Donini, L. M., Prado, C. M. M., Sim, M., & Siervo, M. (2024) · Proceedings of The Nutrition Society · doi:10.1017/s0029665124007559 · Cited by 14
“These changes are associated with an increased production of ROS, resulting in elevated levels of oxidative stress — a key factor in the development and progression of SO (86,87) .”
Wang, J., Cui, Q., Xu, X., & Yang, G. (2025) · BMC Public Health · doi:10.1186/s12889-025-23079-3 · Cited by 14
Huang, Y. C., Chen, S. L., Dong, Y., & Shi, Y. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04374-3 · Cited by 13
“Second, metabolic syndrome has been associated with lower muscular strength [27], and high waist circumference has been positively correlated with reduced hand-grip strength [42].”
BackgroundImmunogenetic Aspects of Sarcopenic Obesity
Mazurkiewicz, Ł., Czernikiewicz, K., & Grygiel‐Górniak, B. (2024) · Genes · doi:10.3390/genes15020206 · Cited by 14
“Increased adipose tissue leads to systemic inflammation, changes skeletal muscle metabolism, and results in SO and decreased oxidative capacity [47].”
BackgroundDietary Inflammatory Potential and Bone Outcomes in Midwestern Post-Menopausal Women
Jackson, M. K., Bilek, L. D., Waltman, N. L., Ma, J., Hébert, J. R., Price, S., Graeff-Armas, L. A., Poole, J. A., Mack, L. R., Hans, D. B., et al. (2023) · Nutrients · doi:10.3390/nu15194277 · Cited by 13
Sarcopenic Obesity: A Comprehensive Approach for Postmenopausal Women
Park, J. Y., Chung, Y., Song, J., Kil, K., Lee, H. Y., Chae, J., & Kim, J.-H. (2024) · Journal of Menopausal Medicine · doi:10.6118/jmm.24004 · Cited by 12
Sarcopenic obesity: pathogenesis, epidemiology and management in older adults
Glavas, C., & Scott, D. S. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2543811 · Cited by 12
“Oxidative stress is another factor that contributes to sarcopenic obesity [24].”
Prajapati, P., Kumar, A., Singh, J., Saraf, S. A., & Kushwaha, S. (2023) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2023.105025 · Cited by 12
Zmerly, H., Ghoch, M. E., Itani, L., Kreidieh, D., Yumuk, V., & Pellegrini, M. (2023) · Nutrients · doi:10.3390/nu15143085 · Cited by 11
“Recently, oxidative stress has been suggested as playing a role in the physiopathology of OA and SO [67,68].”
BackgroundHerrera, I. R., Nogales, F., Díaz‐Castro, J., Moreno‐Fernández, J., Gallego‐López, M. D. C., Ochoa, J. J., Carreras, O., & Ojeda, M. L. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00983-z · Cited by 11
“Moreover, it also contributes to depress global SKM protein synthesis by affecting mTOR signaling; however, most of these studies are still in vitro [18, 51].”
BackgroundQian, S., Huang, T., Wen, Q., Zhang, Y., Chen, J., & Feng, X. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.115 · Cited by 10
Sarcopenic obesity and brain health: A critical appraisal of the current evidence
Booranasuksakul, U., Guan, Z., Macdonald, I. A., Tsintzas, K., Stephan, B. C. M., & Siervo, M. (2025) · Nutrition Bulletin · doi:10.1111/nbu.12725 · Cited by 10
The impact of sarcopenic obesity on cancer clinical outcomes
Köylü, B., Sulu, C., Yumuk, V., & Yumuk, P. F. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.002 · Cited by 8
Role of immunity and inflammation in sarcopenic obesity
Ma, Y. F., Li, X., Lin, X., Zhang, K., & Leng, J. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110077 · Cited by 8
Xie, Y., Deng, D., Wang, S., Li, Z., Mo, T., Wang, Y., & Guo, H. (2026) · npj Science of Food · doi:10.1038/s41538-025-00698-z · Cited by 8
“Obesity represents not merely excessive adiposity but a pathophysiological state that triggers multiple metabolic disturbances, including insulin resistance, dysregulated lipid metabolism, and oxidative stress 27,28 .”
Mahmoodi, M., Shateri, Z., Nouri, M., Vali, M., Nasimi, N., Sohrabi, Z., Dabbaghmanesh, M. H., & Makhtoomi, M. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04790-z · Cited by 8
“1 Kruskal-Wallis U-test has been used. metabolic disorders and changes in muscle function [45].”
MethodAbad-González, Á. L., Martín, S. V., Argente, M., Civera, M., García-Malpartida, K., Juan, C. S., Artero, A., Palmas-Candia, F. X., Perelló-Camacho, E., Salom, C., et al. (2025) · Nutrients · doi:10.3390/nu17030499 · Cited by 8
“The pro-inflammatory state associated with both obesity and aging has detrimental effects on skeletal muscle, inhibiting protein synthesis, reducing oxidative capacity, and exacerbating IR [21].”
InfluentialWang, Z.-Z., Xu, Q., Zhang, Y., Wu, R., Cui, J.-L., Zhou, J., & Hong, J. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00914-3 · Cited by 9
“The OBS has become a valuable tool in epidemiological studies, aiding in the exploration of the associations between OS and the risk of chronic diseases, including cardiovascular disease [13] and cancer [14].”
Xu, X., Qian, Y., Jin, K., Chen, J., Fu, J., Chen, C., & Zhu, Z. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1289909 · Cited by 7
“Metabolic syndrome may be associated with muscle loss through a complex interplay of multiple factors, including pro-in fl ammatory cytokines, insulin resistance, mitochondrial dysfunction and oxidative stress (Sanada et al., 2012; Moon, 2014; Rubio-Ruiz et al., 2019; Gonzalez et al., 2021).”
BackgroundYang, S., Chen, Q., Fan, Y., Zhang, C., & Cao, M. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1377299 · Cited by 7
Kim, C., Kim, M., Lee, S. G., & Hwang, J.-K. (2025) · Nutrients · doi:10.3390/nu17162642 · Cited by 7
“Sarcopenic obesity is primarily characterized by a significant decrease in skeletal muscle mass, largely due to the complex interaction of reduced protein synthesis and increased protein degradation [21].”
Insight on sarcopenic obesity and epicatechin as a promising treatment option
Sabarathinam, S., Dhanasekaran, D., & Ganamurali, N. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102856 · Cited by 7
Yu, W., Chen, J., Jin, S., Fan, X., & Cai, X. (2024) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s463608 · Cited by 6
“19 In our study, we identified several glycosylation-related genes that may influence these pathways.”
BackgroundInter-organ Crosstalk and the Effect on the Aging Process in Obesity
Armutçu, F., & Özen, O. A. (2023) · Current Aging Science · doi:10.2174/1874609816666230223110458 · Cited by 6
Gazda, P., & Glibowski, P. (2026) · Molecules · doi:10.3390/molecules31111837 · Cited by 5
“Additionally, oxidative stress is associated with impaired glucose metabolism and lipid metabolism, circulatory and respiratory dysfunction, mitochondrial impairment, endothelial dysfunction, and chronic inflammation [18].”
The Role of Rehabilitation Program in Managing the Triad of Sarcopenia, Obesity, and Chronic Pain
Vladutu, B. M., Matei, D. V., Genunche-Dumitrescu, A. V., Kamal, C., & Trăistaru, M. R. (2025) · Life · doi:10.3390/life15081174 · Cited by 5
“…and results were interpreted using standardized values adjusted for age and sex [32]; - Pathological values were defined as SMM < 24% of body weight or SMMI < 7 kg/m 2 for men and <5.7 kg/m 2 for women [33]; - Obesity was defined as body fat > 60th percentile: >27% for men and >38% for women [34].”
InfluentialTissue‐specific roles of mitochondrial unfolded protein response during obesity
Carneiro, F. S., Katashima, C. K., Dodge, J. D., Cintra, D. E., Pauli, J. R., da Silva, A. S. R., & Ropelle, E. R. (2024) · Obesity Reviews · doi:10.1111/obr.13791 · Cited by 5
“132,133 Different treatments suggested that it is possible to reverse or alleviate muscle loss and dysfunction in sarcopenic obesity: Huang et al. (2019) reported that resveratrol supplementation increased protein synthesis in the skeletal muscle due to the improvement of mitochondrial metabolism,…”
Vîrgolici, B., Dobre, M.-Z., & Stefan, D. C. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46120800 · Cited by 5
Dikmeer, A., Eren, F. K., Neşelioğlu, S., Şahiner, Z., Hafızoğlu, M., Karaduman, D., Atbas, C., İleri, İ., Doğu, B. B., Cankurtaran, M., et al. (2025) · Medicina · doi:10.3390/medicina61091708 · Cited by 4
“Among these, oxidative stress has emerged as a critical contributor to SO, as it disrupts redox-sensitive signaling pathways and exacerbates both adipose-and muscle-related metabolic derangements [8,9].”
Luo, X., & Jin, W. (2025) · Medicine · doi:10.1097/md.0000000000041122 · Cited by 4
Li, H., Shen, H., Yu, L., Wen, Y., Ren, D., Ding, C., Wang, X., Xie, W., Miao, Y., & Zheng, W. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112833 · Cited by 4
“…such as homocysteine metabolism, DNA methylation (Khanal et al., 2021), insulin resistance (Hong and Choi, 2020), and endothelial dysfunction, oxidative stress (Gonzalez et al., 2021) have also been proposed to explain the association between SO and cognitive impairment (Pasco et al., 2023).”
Kong, F.-S., & Ma, C. (2023) · Clinical Pediatrics · doi:10.1177/00099228231171242 · Cited by 4
Cisternas, Y. C., Díaz, F., Castro‐Piñero, J., Lanuza, F., Lasserre-Laso, N., Leiva-Ordóñez, A. M., Cigarroa, I., Nazar, G., Parra-Soto, S. L., Celis-Morales, C. A., et al. (2023) · Revista Española de Nutrición Humana y Dietética · doi:10.14306/renhyd.27.2.1875 · Cited by 4
Danielewicz, A. L., de Assis, G. F., Cândido, L. M., Mendonça, V. A., Lacerda, A. C. R., Tringali, G., Micheli, R. D., Bondesan, A., de Avelar, N. C. P., & Sartório, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1727488 · Cited by 3
“As a result, obesity and sarcopenia together create a vicious cycle: excess fat not only overloads the body but also stimulates in fl ammatory and catabolic processes that weaken muscles, thereby increasing the risk of falls and other complications in older adults (21).”
Dong, P., Wu, H., Chai, Y., Huang, P., Huang, D., Li, C., Pan, X., Tao, P., Lai, L., Cao, X., et al. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07145-y · Cited by 3
López, I., Mielgo‐Ayuso, J., Fernández‐López, J. R., Aznar, J. M., & Castañeda-Babarro, A. (2025) · Healthcare · doi:10.3390/healthcare13131573 · Cited by 3
Jiang, Y., Jiang, W., Wang, Q., Wei, T., & Chan, L. (2025) · Bioengineering · doi:10.3390/bioengineering12090921 · Cited by 2
“Mitochondrial dysfunction in SO results in increased production of reactive oxygen species (ROS), which can trigger oxidative stress [21].”
Li, H., Chen, Z., & Songlin, X. (2026) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-026-02004-4 · Cited by 2
“Moreover, aging, inflammation in insu - lin resistance, adipose tissue, and conditions like sarcopenic obesity can all contribute to increased ROS production and impaired mitochondrial function [97, 98].”
Sarcopenic obesity and metabolic disorders in ageing
Kurmaev, D. P., Bulgakova, S. V., Treneva, E. V., Косарева, О. В., Sharonova, L. A., Dolgikh, Y. A., & Merzlova, P. Y. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-235-3-134-147 · Cited by 2
Zhe Quan, L. I., Liu, B., Zhou, L., Chen, N., Wang, Y., Yang, S., Fan, X., Wang, Y., & Chen, X. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.04.013 · Cited by 2
Zhao, W., Meng, M., Geng, Y., Qi, R., Zhang, J., Zhang, M., Song, M., & Wang, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1813608 · Cited by 2
A Mini Review Study on Mitochondria and Citrate Synthase
Alzahrani, S., Alharbi, W. K., Khawaji, H., Elashmony, S. M., & Alhindi, Y. Z. (2023) · International Journal Of Pharmaceutical Research And Allied Sciences · doi:10.51847/gzuup6dkxv · Cited by 2
Liu, X., Lou, Y., Chang, Z.-Y., Gu, C., Du, B., & Sun, G. (2025) · Clinics · doi:10.1016/j.clinsp.2025.100674 · Cited by 2
“24 In addition, a recent study has revealed the interaction be-tween ferroptosis and TNF-α and its impact on osteogenesis and angiogenesis, which might be related to the pathogenesis and regenerative therapy of obesity-related osteoporosis.”
Thivent, S., Neder, J. A., Bernard, A., Coudurier, M., Guinot, M., Hérengt, F., Vergès, S., & Marillier, M. (2025) · Experimental Physiology · doi:10.1113/ep091542 · Cited by 1
“Oxidative stress can also impair the function of satellite cells (muscle regeneration and repair) by reducing their proliferation and differentiation capacities (Gonzalez et al., 2021; L’Honore et al., 2018; Renault et al., 2002).”
The association between composite dietary antioxidant index and sarcopenic obesity
Luo, X., & Jin, W. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-01069-x · Cited by 1
Antioxidant Food for Sarcopenia
Vanoh, D. (2025) · Nutrition and health · doi:10.1007/978-3-031-95373-6_5 · Cited by 1
Ma, D., Wu, Y., Yu, J., Xu, C., & Yang, L. (2025) · Nutrition · doi:10.1016/j.nut.2025.113031 · Cited by 1
Jiang, T., Wang, X., 姚旭通, Xia, J., & Liang, J. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156787 · Cited by 1
Systematic review and meta-analysis of biomarkers of sarcopenia and sarcopenic obesity
Yang, Y., Wang, C., Xu, R., Xuan, W., & Chen, X. (2026) · Medicine · doi:10.1097/md.0000000000050799 · Cited by 1
“[56] Mitochondrial dysfunction plays a core role in the pathogenesis of SO.”
Oxidative stress and exogenous constitutional obesity
Александровна, С. О., Darenskaya, M. A., Рычкова, Л. В., Нерисович, Г. И., Astakhova, T. A., & Kolesnikova, L. I. (2025) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20240607 · Cited by 1
Research Progress on Co-Pathogenesis of Non-Alcoholic Fatty Liver Disease and Sarcopenia
杨, 国. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441210
Chainikova, M. A., Kurmaev, D. P., Bulgakova, S. V., & Treneva, E. V. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-228-8-76-88 · Cited by 3
Research Progress on the Relationship between Sarcopenia and Comorbidities in the Elderly
姚, 健. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1582247
Владимирович, Т. В., Mednova, I. A., Pozhidaev, I. V., Викторовна, М. Е., Александрович, П. Д., Vyalova, N. M., Paderina, D. Z., Kornetova, E. G., & Ivanova, S. А. (2025) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2025-2-98-105
Genário, R. (2025) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2025.tde-13112025-174918
SARCOPENIC OBESITY – THE DIAGNOSTIC PARADIGM
Taran, N., Lupaşco, I., Vengher, I., & Ghelimici, T. (2023) · Arta Medica · doi:10.5281/zenodo.10429320
Huang, Y. C., Chen, S. L., Dong, Y., & Shi, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26626084
Kopylov, A. E., Агарков, Н. М., & Abramov, A. A. (2025) · Russian Annals of Ophthalmology · doi:10.17116/oftalma202514106122
Ferraz, V. D. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Dong, L., Zhou, X., Li, L., Miao, H., Zou, T., Zhang, L., Han, Z., Kateer, A., Wu, R., & Aimaitijiang, D. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07118-1
“These mechanisms provide biological plausibility to the relationships that we established in the current study [83–94].”
Castillo, R. L., Jofré‐Saldía, E., Cáceres-Vergara, D., Renard, G. M., & Figueroa, E. G. (2026) · Biomedicines · doi:10.3390/biomedicines14040875
“Sarcopenia-associated adipokine overexpression can promote oxidative stress, facilitating low-density lipoprotein oxidation, impaired cholesterol efflux, and collagen fiber aggregation within fibroatheroma plaques [90,91].”
Liu, Q., Zhang, K., Tang, Y., Zhang, C., Mao, C., Liu, C., & Wu, J. (2026) · Brain and Behavior · doi:10.1002/brb3.71460
“Inflammation and oxidative stress, as key drivers of PD pathogenesis, simultane-Brain ously accelerate muscle loss and neuronal damage (Dalle et al. 2017 ; Gonzalez et al. 2021 ).”
Langa, B. (2025) · ResearchSpace (University of KwaZulu-Natal)
Sun, J., Wen, D., Lin, Y., Tianshuo, Y., Deyu, S., & Yin, X. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124508
Çiçek, O., Kars, M. Y., Turgut, Z. İ., Akkar, I., Dogan, M. H., Saglam, M., & Kızılarslanoğlu, M. C. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-026-00660-9
Zhang, Y., Xu, H., Qu, X., Shi, K., & Kong, C. (2026) · Cardiology · doi:10.1159/000553480
Frigerio, F., & Donini, L. M. (2026) · Endocrinology · doi:10.1007/978-3-030-71067-5_23-1
Паламарчук, О. С., Петрик, К. Ю., Калій, В. В., Horlenko, O. M., & Feketa, V. P. (2025) · Проблеми клінічної педіатрії · doi:10.24144/1998-6475.2024.4.(66).95-101
Zhou, W., Li, P.-T., Li, H.-Y., & Li, W. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179200
Yao, Y., Sun, J., Zou, Y., Zhang, Y., Jiang, Y., & Ji, J. (2026) · PubMed Central · doi:10.3290/j.ohpd.c_2770
“…muscle homeostasis through three primary mechanisms: mitochondrial dysfunction, endoplasmic reticulum stress, and disrupted regulation of muscle mass. 20 Notably, SO and PD share OS as a core pathophysiological hub, and the two conditions may promote each other through a bidirectional cycle.”
Santoso, A. H., Firmansyah, Y., Sari, T., Martin, A., Priyana, A., Wijaya, B. A., Dinali, D., Dzakwan, M. F., Endarti, A. T., Ernawati, et al. (2026) · Obesities · doi:10.3390/obesities6050060
“Cardiometabolic biomarkers, including blood pressure, fasting blood glucose, lipid profile, serum uric acid, and hemoglobin, provide important insights into metabolic homeostasis, systemic inflammation, oxidative stress, and nutritional status [19,20].”
Intramuscular Fat Infiltration and Knee Osteoarthritis: A Systematic Review and Meta‐Analysis
Yu, L., Chen, C., Zhang, G., Huang, Q., Miao, Y., Makihara, Y., & Nishida, Y. (2026) · Physiotherapy Research International · doi:10.1002/pri.70330
“…contractile strength and fatigue resistance, and may be linked to cartilage degeneration and synovitis through pro‐inflammatory adipokines (e.g., leptin, TNF‐α), oxidative stress, and altered joint mechanics (Biltz et al. 2020; Gonzalez et al. 2021; Kawai et al. 2021; Manatrakul et al. 2024).”
Cui, W. (2026) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-026-00802-8
“…can induce mitochondrial dysfunction and protein synthesis imbalance, promoting muscle atrophy, osteoblast apoptosis, and inflammatory responses in muscle, bone, and adipose tissues respectively, forming a cross-tissue oxidative damage vicious cycle (Gonzalez et al. 2021; Zhang et al. 2023).”
Wijaya, B. A., Setiawan, F. V., Endarti, A. T., Firmansyah, Y., & Ernawati, E. (2026) · Prosiding Seminar Nasional Kesehatan Masyarakat Universitas Muhammadiyah Surakarta
Associations between sarcopenic obesity and cognitive function
Booranasuksakul, U. (2026) · Nottingham ePrints (University of Nottingham)
Entrenamiento físico previene la sarcopenia inducida por enfermedad hepática crónica
Rojas, A. P. G. (2023) · Repositorio Institucional Académico , Sistema de Bibliotecas Universidad Andrés Bello (UNAB) (Universidad Andrés Bello (UNAB))
Masdeu, I. G. (2026) · Rovira & Virgili repository
Li, Y., Xia, L., Li, H., Wang, D., Zhang, Z., Fan, G., Zhang, Y., Zhang, S., Zhen, K., Tao, Y., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045575
Leung, W. K. C., Yau, S. S. Y., Yau, C., Lam, S. C., & Suen, L. K. P. (2026) · AIMS Public Health · doi:10.3934/publichealth.20260054
Metadata
- Authors
- Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C.
- Affiliations
- Pontificia Universidad Católica de Valparaíso (CL)
- Pontificia Universidad Católica de Chile (CL)
- ORCID
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2021-01
- Volume
- 2021
- Issue
- 1
- Pages
- 4493817-4493817
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC8526202
- OpenAlex
- W3205252850
- Cited by
- 79
- References
- 160
- Citations by year
- 2026: 20 · 2025: 25 · 2024: 14 · 2023: 17 · 2022: 3
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- CEDENNA (AFB180001, P09-016-F, 1211879, 1201147, 1201039, 1200944)
- Millennium Institute on Immunology and Immunotherapy (AFB180001, P09-016-F, 1211879, 1201147, 1201039, 1200944)
- National Fund for Science and Technological Development (AFB180001, P09-016-F, 1211879, 1201147, 1201039, 1200944)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
- Keywords
- sarcopenic obesity, oxidative stress, sarcopenia, obesity, muscle mass, muscle strength, insulin resistance, inflammatory cytokines, satellite cells, mitochondrial dysfunction, endoplasmic reticulum stress, metabolic syndrome, aging, physical activity
- MeSH terms
- Humans, Middle Aged, Obesity, Oxidative Stress, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.